WE-AB-207B-06: Dose and Biological Uncertainties in Sarcoma.


PURPOSE To understand the clinical impact of key uncertainties in proton therapy potentially affecting the analysis of clinical trials, namely the assumption of using a constant relative biological effectiveness (RBE) of 1.1 compared to variable RBE for proton therapy and the use of analytical dose calculation (ADC) methods. METHODS Proton dose… (More)
DOI: 10.1118/1.4957787


  • Presentations referencing similar topics